REPORTING OF TRANSACTIONS IN ORPHAZYME'S SHARES MADE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

Copenhagen, July 29, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announces that pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), hereby notifies receipt of information of the following transactions in Orphazyme’s shares by persons discharging managerial responsibilities in Orphazyme:

1 Details of the Reporting Person / Closely Associated Person

a) Name

Georges Gemayel

2 Reason for the notification

a) Position/status

Chairman of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Grant of restricted share-units

c) Price(s) and volume(s)

 

Price (s)

Volume(s)

DKK 0

3,451

d) Aggregated information

-       Aggregated volume

-       Price

N/A

e) Date of the transaction

July 29, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Bo Jesper Hansen

2 Reason for the notification

a) Position/status

Deputy Chairman of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Grant of restricted share-units

c) Price(s) and volume(s)

 

Price (s)

Volume(s)

DKK 0

2,689

d) Aggregated information

-       Aggregated volume

-       Price

N/A

e) Date of the transaction

July 29, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Catherine Moukheibir

2 Reason for the notification

a) Position/status

Member of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Grant of restricted share-units

c) Price(s) and volume(s)

 

Price (s)

Volume(s)

DKK 0

1,927

d) Aggregated information

-       Aggregated volume

-       Price

N/A

e) Date of the transaction

July 29, 2019

f) Place of the transaction

Outside a trading venue

1 Details of the Reporting Person / Closely Associated Person

a) Name

Martijn Kleijwegt

2 Reason for the notification

a) Position/status

Member of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Grant of restricted share-units

c) Price(s) and volume(s)

 

Price (s)

Volume(s)

DKK 0

1,927

d) Aggregated information

-       Aggregated volume

-       Price

N/A

e) Date of the transaction

July 29, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Rémi Droller

2 Reason for the notification

a) Position/status

Member of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Grant of restricted share-units

c) Price(s) and volume(s)

 

Price (s)

Volume(s)

DKK 0

1,927

d) Aggregated information

-       Aggregated volume

-       Price

N/A

e) Date of the transaction

July 29, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Martin Bonde

2 Reason for the notification

a) Position/status

Member of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Grant of restricted share-units

c) Price(s) and volume(s)

 

Price (s)

Volume(s)

DKK 0

1,927

d) Aggregated information

-       Aggregated volume

-       Price

N/A

e) Date of the transaction

July 29, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Sten Verland

2 Reason for the notification

a) Position/status

Member of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Grant of restricted share-units

c) Price(s) and volume(s)

 

Price (s)

Volume(s)

DKK 0

1,927

d) Aggregated information

-       Aggregated volume

-       Price

N/A

e) Date of the transaction

July 29, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Anders Hedegaard

2 Reason for the notification

a) Position/status

Member of the Board of Directors

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Grant of restricted share-units

c) Price(s) and volume(s)

 

Price (s)

Volume(s)

DKK 0

1,927

d) Aggregated information

-       Aggregated volume

-       Price

N/A

e) Date of the transaction

July, 29 2019

f) Place of the transaction

Outside a trading venue